LJ SCHOENFIELD, JM LACHIN, RA BAUM, … - Annals of Internal Medicine, 1981 - Am Coll Physicians A double-masked study was conducted to determine the efficacy and safety of
randomly allocated chenodiol (chenodeoxycholic acid, 750 mg/d or 350 mg/d) or
placebo administered for 2 years to 916 patients for dissolution of ... Cited by 141 - Related articles - All 3 versions
H Fromm, JW Roat, V Gonzalez, RP Sarva, S … - Gastroenterology, 1983 - ncbi.nlm.nih.gov In a double-blind controlled study of ursodeoxycholic acid (400 and 800 mg/day)
and chenodeoxycholic acid (375 and 750 mg/day), in comparison with placebo,
ursodeoxycholic acid was significantly more effective than chenodeoxycholic ... Cited by 83 - Related articles - All 4 versions
GD Bell, B Whitney, RH Dowling… - Lancet, 1972 - thelancet.com The bile acid, chenodeoxycholic acid, Summary has been used in the " medical "
treatment of patients with presumed cholesterol gallstones. In fifteen patients
with normally functioning gallbladders, bile lipid composition was measured ... Cited by 130 - Related articles - Cached - All 2 versions
JH Iser, H Dowling, HY Mok, GD Bell - New England Journal of Medicine, 1975 - content.nejm.org We treated 70 patients with gallstones with chenodeoxycholic acid over 3 1/2
years and analyzed the factors influencing the outcome of therapy. This
treatment was unsuccessful in 11 patients with radiopaque gallstones and in ... Cited by 98 - Related articles - All 2 versions
BW Trotman, EJ Petrella, RD Soloway, HM … - Gastroenterology, 1975 - ncbi.nlm.nih.gov A major criterion for the selection of patients with gallstones for treatment
with chenodeoxycholic acid is the radiographic demonstration of lucent
gallstones. In this study, we sought to evaluate the degree of selectivity ... Cited by 42 - Related articles
S Nakagawa, I Makino, T Ishizaki, I Dohi - Lancet, 1977 - ncbi.nlm.nih.gov 44 patients with radiolucent gallstones in gallbladders visible on
cholecystography were randomly alloted to three treatment groups:
ursodeoxycholic acid (600 mg/day), ursodeoxycholic acid (150 mg/day), a ... Cited by 78 - Related articles - All 2 versions
M Sackmann, M Delius, T Sauerbruch, J Holl, … - New England Journal of Medicine, 1988 - content.nejm.org To substantiate the early results of extracorporeal shock-wave fragmentation of
gallstones, we used this nonsurgical procedure to treat 175 patients with
radiolucent gallbladder calculi. Chenodeoxycholic acid and ursodeoxycholic ... Cited by 310 - Related articles - All 4 versions
M Podda, M Zuin, PM Battezzati, C Ghezzi, C … - Gastroenterology, 1989 - ncbi.nlm.nih.gov Chenodeoxycholic acid (CDC) and ursodeoxycholic acid (UDC) have distinct
physicochemical and metabolic properties which, being complementary, should
favor more rapid removal of cholesterol from gallstones when both bile ... Cited by 74 - Related articles - All 5 versions
- ►nih.gov [PDF] MC Bateson, IA Bouchier, DB Trash, DP … - British Medical Journal (Clinical research ed.), 1981 - pubmedcentral.nih.gov Physiologically the electroencephalographic changes com- prised pronounced
reduction in fast-wave activity as the drugs were withdrawn. This drug-related
effect is the reverse of the increase normally seen after administration of ... Cited by 43 - Related articles - All 3 versions
WH Bachrach, AF Hofmann - Digestive diseases and sciences, 1982 - Springer Effectiveness Dissolution of Gallstones. In almost every report of treatment of
patients with cholesterol gallstones with UDCA, the calculation of the success
rate is based on the sum of the complete and partial dissolutions, in this ... Cited by 223 - Related articles - All 4 versions
